Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


South Korea Regulator Orders Up To 1,000 Drugs Pulled For Asbestos

This article was originally published in PharmAsia News

Executive Summary

South Korea's FDA has ordered drug makers, pharmacies and others to trash an estimated 1,000 drugs and medical products containing talc or talcum powders feared to contain asbestos. The names of the products suspected of being contaminated were not yet disclosed. A scare of contamination began with 11 brands of baby powder, but later an estimated 1,000 drugs were known to contain the widely used talc, a key ingredient in making pills, particularly capsules. The Central Pharmaceutical Affairs Review Committee is set to advise the KFDA on which drugs to pull from the market. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts